Marked leukocytosis in response to estramustine phosphate in a hormone-refractory prostate cancer patient
Tatsuo MoritaDepartment of Urology, Jichi Medical University, Tochigi, JapanAbstract: A 67-year-old man was refered to our institution with a complaint of elevated serum prostate-specific antigen (PSA) level (54 ng/mL). Diagnosis was adenocarcinoma of the prostate with a Gleason score of 9, with bon...
Main Author: | Tatsuo Morita |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-04-01
|
Series: | International Medical Case Reports Journal |
Online Access: | http://www.dovepress.com/marked-leukocytosis-in-response-to-estramustine-phosphate-in-a-hormone-a4273 |
Similar Items
-
Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
by: Nakano Kazuhiko, et al.
Published: (2012-02-01) -
Estramustine phosphate in the treatment of hormone escape prostatic carcinoma - a 3 year follow-up
by: Altaf H Syed, et al.
Published: (2003-01-01) -
Estramustine-Induced Suicidal Erythrocyte Death
by: Rosi Bissinger, et al.
Published: (2013-11-01) -
Pheochromocytoma with Markedly Abnormal Liver Function Tests and Severe Leukocytosis
by: Chai Ryoung Eun, et al.
Published: (2014-03-01) -
Pathogenesis of prostate cancer and hormone refractory prostate cancer
by: J S Girling, et al.
Published: (2007-01-01)